Delivery Order SPE2DB20D1110-SPE2DB25FJ90B

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,095.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,404,858 units of Fexofenadine HCL 180 mg tablets in 500-count packages. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, which enables the agency to efficiently procure...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,223.49 firm fixed-price delivery order is for the supply of Fexofenadine Hydrochloride 180 mg Tablets, a prescription medication. The award has an ultimate completion date of August 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $5,239.09 firm fixed price delivery order is for the supply of 4,564,631,325 fexofenadine hydrochloride 180 mg tablets to the DLA. This award is under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,061 firm-fixed-price delivery order is for the supply of 4,566,211,485 units of Fexofenadine HCL 180 mg tablets in 500-count containers, with a period of performance through October 28, 2024. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,690.23, is a delivery order to provide Fexofenadine HCL 180 mg tablets. The contract has a period of performance through January 28, 2025 and uses a firm fixed price pricing type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,180.81 firm-fixed-price delivery order is for the supply of 4,565,962,852 units of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of September 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a $1,227.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567033421 fexofenadine HCl 180 mg tablets, with a performance period running through January 27, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is a delivery order valued at $2,620.16 issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fexofenadine HCL 180 mg tablets, a generic antihistamine medication. The award is not designated as a set-aside contract. It is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fexofenadine Hydrochloride 180 mg Tablets in quantities of 500 per bottle. The contract has a firm fixed price of $3,470.64 and a completion date of September 10, 2024. The award is not set aside for any particular business type. This contract appears to be a delivery order issued under a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,014.35 firm-fixed-price delivery order is for the supply of 4,564,016,983 units of Fexofenadine HCl 180 mg tablets, a medication used to treat allergies. The contract has an ultimate completion date of March 20, 2024 and was awarded on March 19, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB25FJ90B
    Delivery Order

This federal contract award, valued at $3,473.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fexofenadine Hydrochloride 180 mg tablets, a generic pharmaceutical product.

The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating that it was awarded through open competition. Amerisourcebergen is the prime contractor on this award, with no major subcontractors listed.

Generated 4/28/25, 9:42 AM